Surgical Robotics and Outpatient Expansion Transform the US MedTech Landscape

Investment Banking

Supported by favorable demographic shifts, an increasing chronic disease burden, and an accelerated migration of surgical procedures into outpatient settings, the US medical device market is projected to reach $315 billion by 2032, expanding at a 6.8% CAGR. Technological integration particularly continuous glucose monitoring (CGM), AI-enabled software, and surgical robotics is establishing recurring revenue streams and decentralizing care delivery. While MedTech manufacturers must navigate complex reimbursement environments, data governance frameworks, and hospital margin constraints, competitive advantage is increasingly determined by pairing technological innovation with quantifiable clinical outcomes, provider productivity, and disciplined commercial execution.

Key Takeaways

  • The US MedTech market is projected to grow from $199.1 billion in 2025 to $315 billion by 2032 at a 6.8% CAGR.
  • Procedures are rapidly shifting into Ambulatory Surgery Centers (ASCs), with over 500 procedures added to Medicare’s ASC Covered List for 2026 alone.
  • The US surgical robotics market is forecasted to reach $2 billion in 2026, growing at a 10.5% CAGR through 2035.
  • AI integration is accelerating, with over 1,300 FDA-authorized AI-enabled medical devices and 45% of surveyed MedTech leaders deploying agentic AI in production.
  • Equipment manufacturers are shifting away from lump-sum capital purchases toward recurring revenue models via operating leases, usage-based pricing, and consumables.
  • Continuous Glucose Monitoring (CGM) is expanding beyond insulin-treated diabetes into broader consumer metabolic health and non-insulin type 2 diabetes management.
  • Digital health funding rebounded in 1H26 to $7.4 billion across 244 deals, with capital increasingly concentrated in mega-rounds of $100M+.
  • Private equity and strategic M&A buyers are prioritizing MedTech assets that demonstrate clear reimbursement visibility, high cash generation, and operational efficiency.
post-image

Download Whitepaper


Related Ins(AI)ghts

Related Tags

AI - Artificial IntelligenceInvestment BankingPrivate Equity

About SG Analytics

SG Analytics (SGA) is a leading global data and AI consulting firm delivering solutions across AI, Data, Technology, and Research. With deep expertise in BFSI, Capital Markets, TMT (Technology, Media & Telecom), and other emerging industries, SGA empowers clients with Ins(AI)ghts for Business Success through data-driven transformation.


A Great Place to Work® certified company, SGA has a team of over 1,600 professionals across the U.S.A, U.K, Switzerland, Poland, and India. Recognized by Gartner, Everest Group, ISG, and featured in the Deloitte Technology Fast 50 India 2024 and Financial Times & Statista APAC 2025 High Growth Companies, SGA delivers lasting impact at the intersection of data and innovation.

Driving

AI-Led Transformation

Contact Us
We'd Love to Hear from You!